United States · 
Who invested in Ember Therapeutics?
Ember Therapeutics's investors include Third Rock Ventures.
United States · Series A startup
Who invested in Ember Therapeutics
One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Ember Therapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$34Mraised across 1 round since 2011, from 1 source
- Latest round
- Series A, $34MDec 2011
- Investors
- 1
The rounds
- Dec 2011
Funding filed with regulators
Ember Therapeutics filed one raise, $3.2M in all. Filings say how much was sold and to how many investors; they never name the investors.
- Dec 2011$3.2MSEC Form D
Founders and team
From the SEC filings it signed: 3 on the team.
- Kevin GillisExecutive Officeri
- Louis TartagliaExecutive Officer, Directori
- Mitchell BloomExecutive Officeri
On the board, as filediBruce SpiegelmanDan Lynch
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Ember Therapeutics
How much has Ember Therapeutics raised?
Ember Therapeutics has raised $34M across 1 round since 2011.
When did Ember Therapeutics last raise?
Ember Therapeutics's most recent round was a Series A of $34M in Dec 2011.
What was Ember Therapeutics's biggest round?
Its most recent round, $34M in Dec 2011, is also its largest on record.
Who backed Ember Therapeutics first?
Ember Therapeutics's first round on record, in Dec 2011, was backed by Third Rock Ventures.
What stage is Ember Therapeutics at?
Ember Therapeutics's latest named round is a Series A, in Dec 2011.
Where is Ember Therapeutics based?
Ember Therapeutics is based in the United States.
Companies like Ember Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.